Quick Answer
INTERPACE BIOSCIENCES, INC. reported Revenue From Contract With Customer Excluding Assessed Tax of $38.73 million for the year ending 2025.
- INTERPACE BIOSCIENCES, INC. showed a decrease of -17.5% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from INTERPACE BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), INTERPACE BIOSCIENCES, INC.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 143.6%.
- Historical annual values: Fiscal year 2025: $38.73 million | Fiscal year 2024: $46.93 million | Fiscal year 2023: $40.04 million | Fiscal year 2022: $31.84 million | Fiscal year 2021: $33.12 million | Fiscal year 2020: $32.40 million | Fiscal year 2019: $24.22 million | Fiscal year 2018: $21.90 million | Fiscal year 2017: $15.90 million.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: